These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 113021)

  • 1. [Influence of ethyl cinepazate maleate on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Mercuro G; Lai C
    Boll Soc Ital Cardiol; 1978; 23(1):265-80. PubMed ID: 113021
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of oxyfedrine on exercise performance and systolic time intervals in patients of angina pectoris.
    Puri VK; Agarwal SK; Mehrotra A; Hasan M
    Indian Heart J; 1984; 36(4):226-30. PubMed ID: 6389320
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of verapamil on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):248-64. PubMed ID: 754777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term treatment of coronary insufficiency with 6753 M.D. (ethyl cinepazate maleate)].
    Neirinck M; Parent J; Frère A
    Brux Med; 1973 Jun; 53(6):397-400. PubMed ID: 4727316
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observations on the action of ethyl cinepazate maleate in 67 patients with coronary insufficiency].
    Pino G
    Minerva Cardioangiol; 1974 Dec; 22(12):852-66. PubMed ID: 4459729
    [No Abstract]   [Full Text] [Related]  

  • 8. [Place and value of the maleate of ethyl cinepazate (vascoril) among the anti-angina agents].
    Garbarg S
    Boll Soc Ital Cardiol; 1976; 21(9):1735-7. PubMed ID: 1031333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of lidoflazine in angina pectoris. A long-term double-blind study].
    Lehmann H; Hochrein H
    Med Klin; 1976 Jan; 71(5):189-96. PubMed ID: 814396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 11. Antianginal drugs for stable angina pectoris.
    Aronow WS
    Ration Drug Ther; 1982 Jan; 16(1):1-7. PubMed ID: 6799985
    [No Abstract]   [Full Text] [Related]  

  • 12. [The ergometric test in the evaluation of the effects of nifedipine, verapamil and ethyl cinepazat maleate in angina of effort].
    Novo S; Davì G; Riolo F; Pinto A; Avellone G; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(2):139-48. PubMed ID: 7236439
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of nifedipine on the effort tolerance test in angina pectoris. Comparison with placebo and trinitroglycerine.
    Cherchi A; Fonzo R; Bina M
    G Ital Cardiol; 1974; 4(5):565-74. PubMed ID: 4215687
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a sustained-release buccal nitroglycerin preparation in stable angina pectoris.
    Grasso S; Pesciatini F; Ugolini C; Lepore R; Cerri B
    Int J Clin Pharmacol Res; 1988; 8(2):131-7. PubMed ID: 3132428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit].
    Volkov VS; Bratoliubov VP
    Ter Arkh; 1986; 58(5):124-7. PubMed ID: 3090730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study.
    Colombo G; Favini G; Aglieri S; Pollavini G; de Vita C
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):211-4. PubMed ID: 3922903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to the hemodynamic and antianginal effects of the organic nitrates.
    Parker JO
    Z Kardiol; 1985; 74 Suppl 1():45-9. PubMed ID: 3922142
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacodynamics of Sustak and Nitrong in patients with angina pectoris].
    Metelitsa VI; Nikolenko SA; Nazarenko VA; Savvateev KL; Vygodin VA
    Ter Arkh; 1979; 51(1):40-9. PubMed ID: 107611
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitrite therapy of stenocardia].
    Meesmann W; Amann L
    Dtsch Med Wochenschr; 1971 Sep; 96(36):1444-9. PubMed ID: 4397998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.